
DeeboAI builds clinical intelligence software, risk assessment tools, and custom AI systems that help healthcare teams and operators move faster with more confidence. We turn high-stakes workflows into practical, production-ready products.
2
Current flagship healthcare products on the roadmap
1
Mayo Clinic-aligned risk assessment collaboration highlighted today
100%
Practical builds designed around real operator workflows
Founded by Amadou Touré, DeeboAI is an applied AI company focused on clinical intelligence, risk assessment, and production-grade software for teams working in complex environments. Past work including Deebo Studio helped shape our product instincts, but today our focus is healthcare tooling and durable operator-facing systems.
Clinical AI
Risk assessment, medication intelligence, and decision-support software built for real healthcare workflows.
Healthcare
Patient-friendly transparency and clinician-aligned product design embedded into existing care systems.
Enterprise
Full-stack SaaS, analytics infrastructure, and custom software for operators scaling specialized services.
Every build starts with a real operator, clinician, or creative in mind.
Emerging research moves from lab to production through rapid experimentation.
We ship intuitive tools that scale without sacrificing human context.
Trajectory
Our throughline has stayed the same: build software around the actual workflow. That lesson carried from early product work into today's healthcare and decision-support platforms.
MyelomaRisk Collaboration Begins
The underlying MyelomaRisk collaboration started before DeeboAI existed, laying the foundation for later clinical risk tooling work.
Applied AI Product Work
Early work on products including Deebo Studio sharpened our approach to workflow-native AI and rapid product iteration.
Healthcare Focus Deepened
Expanded clinical advisory and product discovery efforts around medication transparency and decision support.
ZynthRx Platform Direction
Refined our medication intelligence platform around patient-friendly understanding, provider context, and workflow fit.
MyelomaRisk Joins DeeboAI
The ongoing MyelomaRisk work was brought into DeeboAI's portfolio, connecting a 2023 clinical collaboration to the company's healthcare product direction.
Strategic partners for teams building practical AI products from discovery through deployment.
End-to-end ML product teams delivering automation, NLP, and predictive analytics.
High-impact marketing and corporate websites handcrafted without relying on AI.
Regulated-ready SaaS and data products for healthcare teams and specialized operators.
Workshop To Launch
Crafting intelligent solutions that free teams to focus on what matters.
Patient-friendly medication intelligence layered into care workflows with clearer indications, context, and decision support.
Explore the roadmap→Risk stratification and prognosis tooling for multiple myeloma and related plasma cell disorders, carried into DeeboAI in 2026 after the collaboration began in 2023.
Explore the roadmap→We partner with teams that need custom AI software, clinical workflow tools, and operator-ready systems rather than off-the-shelf demos.